Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 21Neoplasms 8Prostatic Neoplasms 7Glioblastoma 6Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Polycystic Ovary Syndrome 4Ovarian Neoplasms 4Endometrial Neoplasms 4Urinary Bladder Neoplasms 3Skin Neoplasms 3Pancreatic Neoplasms 3Melanoma 3Lung Neoplasms 3Head and Neck Neoplasms 3Glioma 3Depression 3Colorectal Neoplasms 3Brain Neoplasms 3Thyroid Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Non-Muscle Invasive Bladder Neoplasms 2Neuroma, Acoustic 2Neurofibromatosis 2 2Myelodysplastic Syndromes 2Multiple Myeloma 2Medulloblastoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

entinostat 1Medroxyprogesterone Acetate 1Hysterectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Has results × FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma × Clear all
NCT03018249 2021-11-16

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

National Cancer Institute (NCI)

Phase EARLY_PHASE1 Completed
50 enrolled 12 charts
Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡